Fluticasone Propionate and Salmeterol (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Fluticasone Propionate and Salmeterol drug offered from Teva Pharmaceuticals USA, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Fluticasone Propionate and Salmeterol |
| SUBSTANCE NAME: | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER, METERED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-04-20 |
| END MARKETING DATE: | 0000-00-00 |
Fluticasone Propionate and Salmeterol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fluticasone Propionate and Salmeterol from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 55; 14(ug/1; ug/1) |
| START MARKETING DATE: | 2017-04-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-3607_f99e48bc-787f-45a7-bf88-ab9a030fc02e |
| PRODUCT NDC: | 0093-3607 |
| APPLICATION NUMBER: | NDA208799 |
Other FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers:
